Larad, Inc. is an Ohio C-Corp founded on March 15, 2013 and is a self-directed start up with an exclusive worldwide license from The Ohio State University for the IP developed by Dr. Jackwood, a professor at the university. Larad was formed to develop platform VLP technology specifically to address vaccines and diagnostics for animal diseases. Our mission is to improve animal health through the prevention and diagnosis of diseases that affect food animals as well as companion animals.
Through our innovative VLP technology we are able to provide vaccines and diagnostic reagents that easily keep pace with the ever changing kaleidoscope of viruses that cause animal diseases and threaten the global food supply.
Larad, Inc. is located at the BioHio Research Park on the campus of the Ohio Agricultural Research and Development Center (OARDC) in Wooster, Ohio, USA
Larad employs a CEO (H. Ken Rudd), a Project Director (Dr. Linda Michel) and Chief Science Officer (Dr. Daral Jackwood).
Dr. Daral Jackwood, Chief Science Officer
Dr. Jackwood received his Ph.D. from The Ohio State University (OSU) in the fields of microbiology and molecular virology. Following a post-doctorate in Biotechnology at Battelle Columbus Laboratories, he joined the OSU faculty in the Food Animal Health Research Program at the Ohio Agricultural Research and Development Center (OARDC) in Wooster, OH. For over 30 years his research has focused on the molecular characteristics of Birnaviruses. He is the inventor on 6 issued patents. He, along with PD Dr. Linda Michel, received the 2016 OARDC Director's Innovator of the Year Award for their work on development and commercialization of VLP vaccines.
Dr. Linda Michel, Project Director
Dr. Michel received her Ph.D. in microbiology from the Center for Microbial Ecology at Michigan State University and completed post-docs at Michigan State University and The Ohio State University. She is an experienced molecular biologist who is responsible for leading VLP vaccine projects from development through USDA conditional licensure. She is also the head of Larad's diagnostic testing service.
H. Ken Rudd, CEO
H. Ken Rudd has had a wide ranging career in the Biologics Industry with over 40 years of experience in research, quality control, production, marketing, technical service and sales for companies that include Glaxo, Duphar, Salsbury, Solvay and Merial. His last full-time position was Director of Marketing and Technical Services for Merial Select, a global leader in animal vaccines. In 2002, he founded and currently runs BioBusiness Consultants. This consultancy business has involved wide ranging technical and marketing functions within the poultry biologic arena.
A Board of Directors was established shortly after Larad was founded in 2013. The Board, composed of people with both biotechnology and business experience, meets quarterly and is very active in directing and shaping the future of Larad.